Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GROUP: Gabapentin to Reduce Opioid Use Postoperatively in Children
NCT04724252Phase 3Recruiting
- Sponsor
- University of California, Davis
- Start
- Aug 2021
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gabapentin in postoperative pain (2 arms), sponsored by University of California, Davis. Primary endpoint: Amount of pain medication needed. Started Aug 2021; status: recruiting.
02
Drugs
gabapentin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04724252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04724252.